Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies.
Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies.
复制标题
DOI:
10.3390/pharmaceutics13010026
复制
发表时间:
2020-12-25
期刊:
影响因子:
5.4
通讯作者:
Mansour HM
中科院分区:
文献类型:
--
作者:
Alabsi W;Al-Obeidi FA;Polt R;Mansour HM
The purpose of this study was to formulate Lactomorphin (MMP2200) in its pure state as spray-dried(SD) powders, and with the excipient Trehalose as co-spray-dried(co-SD) powders; for intranasal and deep lung administration with Dry Powder Inhalers (DPI). Lactomorphin is a glycopeptide which was developed for the control of moderate to severe pain. Particles were rationally designed and produced by advanced spray drying particle engineering in a closed mode from a dilute organic solution. Comprehensive physicochemical characterization using different analytical techniques was carried out to analyze the particle size, particle morphology, particle surface morphology, solid-state transitions, crystallinity/non-crystallinity, and residual water content. The particle chemical composition was confirmed using attenuated total reflectance-Fourier-transform infrared (ATR-FTIR), and Confocal Raman Microscopy (CRM) confirmed the particles’ chemical homogeneity. The solubility and Partition coefficient (LogP) of Lactomorphin were determined by the analytical and computational methodology and revealed the hydrophilicity of Lactomorphin. A thermal degradation study was performed by exposing samples of solid-state Lactomorphin to a high temperature (62 °C) combined with zero relative humidity (RH) and to a high temperature (62 °C) combined with a high RH (75%) to evaluate the stability of Lactomorphin under these two different conditions. The solid-state processed particles exhibited excellent aerosol dispersion performance with an FDA-approved human DPI device to reach lower airways. The cell viability resazurin assay showed that Lactomorphin is safe up to 1000 μg/mL on nasal epithelium cells, lung cells, endothelial, and astrocyte brain cells.
登录
查看更多内容
影响因子:
8
作者:
Duan, Jinghua;Vogt, Frederick G.;Mansour, Heidi M.
通讯作者:
Mansour, Heidi M.
影响因子:
--
作者:
Currier, Glenn;Walsh, Patrick
通讯作者:
Walsh, Patrick
影响因子:
9.8
作者:
Alexander-Williams, JM;Rowbotham, DJ
通讯作者:
Rowbotham, DJ
影响因子:
8.8
作者:
Blessy M;Patel RD;Prajapati PN;Agrawal YK
通讯作者:
Agrawal YK
DOI:
10.1124/jpet.104.069393
发表时间:
2004-10-01
影响因子:
3.5
作者:
Elmagbari, NO;Egleton, RD;Bilsky, EJ
通讯作者:
Bilsky, EJ